Current
3.1×
5-Year Average
5.0×
All-Time High
7.4×
All-Time Low
1.5×
P/B Ratio daily chart for Abbott Laboratories (ABT)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/B Ratio for Abbott Laboratories (ABT) from 2001 to 2025
| 2025 | $218.88B | $52.13B | 4.2× | +0.1× | |
| 2024 | $195.87B | $47.66B | 4.1× | -0.8× | |
| 2023 | $190.87B | $38.60B | 4.9× | -0.3× | |
| 2022 | $190.79B | $36.69B | 5.2× | -1.7× | |
| 2021 | $248.28B | $35.80B | 6.9× | +1.0× | |
| 2020 | $193.93B | $32.78B | 5.9× | +1.0× | |
| 2019 | $153.09B | $31.09B | 4.9× | +0.8× | |
| 2018 | $126.98B | $30.52B | 4.2× | +0.9× | |
| 2017 | $99.51B | $30.90B | 3.2× | +0.5× | |
| 2016 | $56.57B | $20.54B | 2.8× | -0.4× | |
| 2015 | $66.14B | $21.21B | 3.1× | -0.0× | |
| 2014 | $67.89B | $21.53B | 3.2× | +0.8× | |
| 2013 | $59.34B | $25.17B | 2.4× | +0.5× | |
| 2012 | $48.85B | $26.72B | 1.8× | +0.1× | |
| 2011 | $42.32B | $24.44B | 1.7× | +0.1× | |
| 2010 | $35.62B | $22.39B | 1.6× | -0.2× | |
| 2009 | $39.87B | $22.86B | 1.7× | -0.5× | |
| 2008 | $39.46B | $17.48B | 2.3× | -0.1× | |
| 2007 | $41.47B | $17.78B | 2.3× | -0.2× | |
| 2006 | $35.89B | $14.05B | 2.6× | +0.6× | |
| 2005 | $28.85B | $14.42B | 2.0× | -0.4× | |
| 2004 | $34.74B | $14.33B | 2.4× | -0.1× | |
| 2003 | $32.73B | $13.07B | 2.5× | -0.1× | |
| 2002 | $28.09B | $10.66B | 2.6× | -1.7× | |
| 2001 | $39.05B | $9.06B | 4.3× | — |
- 20254.2×
- 20244.1×
- 20234.9×
- 20225.2×
- 20216.9×
- 20205.9×
- 20194.9×
- 20184.2×
- 20173.2×
- 20162.8×
- 20153.1×
- 20143.2×
- 20132.4×
- 20121.8×
- 20111.7×
- 20101.6×
- 20091.7×
- 20082.3×
- 20072.3×
- 20062.6×
- 20052.0×
- 20042.4×
- 20032.5×
- 20022.6×
- 20014.3×
About P/B Ratio at Abbott Laboratories (ABT)
Abbott Laboratories (ABT) P/B ratio is 3.1× as of June 5, 2026. The 5-year average is 5.0×. The sector median currently stands at 3.4×. The current ratio is at the 2th percentile of its own 10-year history.
Abbott Laboratories (ABT) historical P/B ratio has ranged from a low of 1.5× (2011) to a high of 7.4× (2021) in the available daily series.
The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.
Abbott Laboratories P/B Ratio by Year
Abbott Laboratories P/B Ratio 2025: 4.2×
Abbott Laboratories (ABT) P/B ratio in 2025 was 4.2×, expanded from 4.1× the prior year.
Abbott Laboratories P/B Ratio 2024: 4.1×
Abbott Laboratories (ABT) P/B ratio in 2024 was 4.1×, contracted from 4.9× the prior year.
Abbott Laboratories P/B Ratio 2023: 4.9×
Abbott Laboratories (ABT) P/B ratio in 2023 was 4.9×, contracted from 5.2× the prior year.
Abbott Laboratories P/B Ratio 2022: 5.2×
Abbott Laboratories (ABT) P/B ratio in 2022 was 5.2×, contracted from 6.9× the prior year.
Abbott Laboratories P/B Ratio 2021: 6.9×
Abbott Laboratories (ABT) P/B ratio in 2021 was 6.9×.
Sector peers by P/B Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/B Ratio — table
Healthcare peers of Abbott Laboratories (ABT), ranked by P/B ratio.
| 2.9× | |
| 2.7× | |
| 2.6× | |
| 2.6× | |
| 2.5× | |
| 2.5× | |
| 2.4× | |
| 2.4× | |
| 2.3× | |
| 1.8× | |
| 1.8× | |
| 1.7× | |
| 1.7× | |
| 1.6× | |
| 1.5× | |
| 1.5× | |
| 1.5× | |
| 1.4× | |
| 1.4× | |
| 1.4× | |
| 1.2× | |
| 1.2× | |
| 1.1× | |
| 1.1× | |
| 0.8× |
- 2.7×
- 2.4×
- 2.3×
- 1.8×
- 1.7×
- 1.4×
- 1.4×
- 1.2×
- 1.1×
- 1.1×
- 0.8×
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric